COVID - 19 Vaccination Update - Day 543 - Prevention is better than cure

Spread the Message

Read Time:1 Minute, 41 Second

Posted On: 12 JUL 2022 8:31 PM by PIB Delhi

India’s COVID-19 vaccination coverage has crossed 199 Crore landmark milestone (1,99,11,38,096) today. More than 9 lakh (9,77,227) Vaccine Doses have been administered till 7 pm today. The daily vaccination tally is expected to increase with the compilation of the final reports for the day by late tonight.

The cumulative coverage of vaccine doses, segregated based on population priority groups, is as follows:

Cumulative Vaccine Dose Coverage
HCWs	1^st Dose	10409922
	2^nd Dose	10075314
	Precaution Dose	5924479
FLWs	1^st Dose	18426391
	2^nd Dose	17644426
	Precaution Dose	11115779
Age Group 12-14 years	1^st Dose	37622229
	2^nd Dose	25442969
Age Group 15-18 years	1^st Dose	60738872
	2^nd Dose	49732424
Age Group 18-44 years	1^st Dose	558709598
	2^nd Dose	504737426
	Precaution Dose	4163130
Age Group 45-59 years	1^st Dose	203537643
	2^nd Dose	194287223
	Precaution Dose	3119921
Over 60 years	1^st Dose	127335446
	2^nd Dose	121394922
	Precaution Dose	26719982
Cumulative 1^st dose administered		1016780101
Cumulative 2^nd dose administered		923314704
Precaution Dose		51043291
Total		1991138096

Today’s achievement in the vaccination exercise, segregated by population priority groups, is as follows:

Date: 12^th July, 2022 (543^rd Day)
HCWs	1^st Dose	58
	2^nd Dose	546
	Precaution Dose	16661
FLWs	1^st Dose	187
	2^nd Dose	1373
	Precaution Dose	85356
Age Group 12-14 years	1^st Dose	59630
	2^nd Dose	129222
Age Group 15-18 years	1^st Dose	16762
	2^nd Dose	60551
Age Group 18-44 years	1^st Dose	22787
	2^nd Dose	191903
	Precaution Dose	69857
Age Group 45-59 years	1^st Dose	3579
	2^nd Dose	47255
	Precaution Dose	29895
Over 60 years	1^st Dose	2908
	2^nd Dose	31719
	Precaution Dose	206978
Cumulative 1^st dose administered		105911
Cumulative 2^nd dose administered		462569
Precaution Dose		408747
Total		977227

The vaccination exercise as a tool to protect the most vulnerable population groups in the country from COVID-19 continues to be regularly reviewed and monitored at the highest level.